Curia’s Patented Process For Intermediates Useful For Manufacturing The API Olopatadine HCl
white paper
internal
A process such as the one provided by Curia’s scientists has several advantages since the use of very dangerous reagents such as n-butyl lithium is not required, and lower relative amounts of reagents than those previously described in prior art documents for this type of reactions are used, allowing better isolation and higher purity of the product without having to use costly purification techniques (e.g., chromatography), thus making this process more advantageous from the industrial point of view.